NervGen Pharma Corp. (“NervGen” or the “Company”) , a clinical-stage biopharmaceutical company developing first-in-class neuroreparative…
karnottNovember 24, 2025
Glen was a Distinguished Professor at SFU with joint appointments in Biomedical Physiology and Kinesiology…
karnottNovember 21, 2025
We are moving into a new era of genomic medicines that will target cancer, viruses…
karnottNovember 20, 2025
Every day in hospitals and long-term care homes, people with limited mobility develop painful pressure…
karnottNovember 20, 2025
A study published in Nature Medicine has uncovered biomarkers that could help select the most…
karnottNovember 19, 2025
Dr. Blair Leavitt is a full Professor in the Department of Medical Genetics & the…
karnottNovember 19, 2025
A new study, led by St. Paul’s Hospital respirologist Dr. Alyson Wong and funded by…
karnottNovember 18, 2025
With support from a new $3-million Terry Fox Frontiers Program Project Grant, researchers from the…
karnottNovember 18, 2025
Impaired amyloid beta (Aβ) clearance contributes to sporadic Alzheimer's disease (AD). This study investigated retinal…
karnottNovember 17, 2025
